Literature DB >> 17363837

Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men.

Toshiko Tanaka1, Jose M Ordovas, Javier Delgado-Lista, Francisco Perez-Jimenez, Carmen Marin, Pablo Perez-Martinez, Purificacion Gomez, Jose Lopez-Miranda.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a ligand-dependent transcription factor that plays a key role in lipid and glucose homeostasis. This study evaluated whether variants of PPARalpha are associated with postprandial lipemia. Subjects were given a single fat load composed of 60% calories as fat, 15% as protein, and 25% as carbohydrate. Blood was drawn every hour from baseline to 6 h, then every 2.5 h to 11 h to determine triglyceride (TG) levels. The minor allele of the nonsynonymous p.Leu162Val variant was associated with higher fasting total cholesterol, LDL-cholesterol, and apolipoprotein B. There were no significant associations with all of the postprandial parameters examined. Conversely, the noncoding variant c.140+5435T>C was not associated with fasting lipid concentrations but was significantly associated with decreased postprandial TG and cholesterol in the small TG-rich lipoprotein particle. Although the minor allele carriers displayed lower mean concentrations of TG and cholesterol throughout the postprandial period, the differences were most pronounced in the latter period. These data suggest that PPARalpha variants may modulate the risk of cardiovascular disease by influencing both fasting and postprandial lipid concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363837     DOI: 10.1194/jlr.M700066-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; H Puckett; J Oliver; G Nielsen; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-19       Impact factor: 4.219

Review 2.  PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

Authors:  Alejandra V Contreras; Nimbe Torres; Armando R Tovar
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

3.  Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han population.

Authors:  Wei Fan; Chao Shen; Ming Wu; Zheng-Yuan Zhou; Zhi-Rong Guo
Journal:  Genet Test Mol Biomarkers       Date:  2015-06-22

Review 4.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 5.  Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

Authors:  Chen Dong; Hui Zhou; Chong Shen; Lu-Gang Yu; Yi Ding; Yong-Hong Zhang; Zhi-Rong Guo
Journal:  World J Diabetes       Date:  2015-05-15

6.  Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism.

Authors:  Iwona Rudkowska; Christophe Garenc; Patrick Couture; Marie-Claude Vohl
Journal:  Genes Nutr       Date:  2009-07-08       Impact factor: 5.523

7.  Differences in transcriptional activation by the two allelic (L162V Polymorphic) variants of PPARα after Omega-3 fatty acids treatment.

Authors:  Iwona Rudkowska; Mélanie Verreault; Olivier Barbier; Marie-Claude Vohl
Journal:  PPAR Res       Date:  2009-02-25       Impact factor: 4.964

Review 8.  A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.

Authors:  Kathryn Z Guyton; Weihsueh A Chiu; Thomas F Bateson; Jennifer Jinot; Cheryl Siegel Scott; Rebecca C Brown; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031

9.  PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

Authors:  Sharon Cresci
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  Effects of Eicosapentaenoic Acid Supplementation on Lipid and Lipoprotein Profile in Hypertriglyceridemic Subjects with Different Proliferator-activated Receptor Alpha Genotypes.

Authors:  Hamideh Pishva; Parvin Mehdipour; Mohammad Reza Eshraghian; Soltan-Ali Mahboob
Journal:  Int J Prev Med       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.